Gemeinschaftspraxis Drs. Grosskopf

The site is conducting research on the immune response to a novel respiratory syncytial virus vaccine in adults aged 60 and older, aiming to improve protection against seasonal infections.

• Evaluation of humoral immunity after revaccination
• Assessment of vaccine safety in elderly participants
• Timing of booster doses across different RSV seasons

Gemeinschaftspraxis Drs. Grosskopf contributes valuable data to the field of respiratory viral prevention.

A comparative study is testing a new topical formulation containing clotrimazole and betamethasone dipropionate for the treatment of moderately to severely inflamed candidiasis of the skin, with the goal of enhancing therapeutic outcomes.

• Comparison of combination ointment versus standard therapy
• Safety profile of anti‑fungal and anti‑inflammatory agents together
• Patient‑reported symptom relief and healing rates

The practice’s dermatology focus supports advances in managing fungal skin infections.

Research at the center also explores broader viral health by monitoring immune responses to revaccination with an RSVPreF3 OA vaccine, seeking to strengthen defenses against common respiratory viruses in older adults.

• Immunogenicity across multiple vaccination seasons
• Cross‑reactivity with other respiratory pathogens
• Long‑term safety monitoring post‑vaccination

These efforts align with the site’s commitment to combating viral diseases within the community.